Connect with us


PARADISE-MI Makes Me Question the Benefits of Sacubitril/Valsartan – Medscape

Sacubitril valsartan (Entresto), deemed ‘the Big E’ by some clinicians, has fallen short in 2 of 3 clinical trials. The latest, presented at the ACC 2021 scientific…



Article feature image

The PARADISE-MI trial comparing sacubitril/valsartan to ramipril in patients with left ventricular dysfunction after myocardial infarction (MI) and clinical heart failure led off the late-breaking clinical trial session at the American College of Cardiology (ACC) 2021 Scientific Session. Organizers tend to reserve this slot for the biggest newsmakers.
And if the angiotensin neprilysin inhibitor had been associated with a statistically significant reduction of the primary endpoint of cardiovascular…

Click here to view the original article.

Continue Reading


You might also like ...

Article feature image
We found more than 54,000 viruses in people’s poo — and 92% were previously unknown to science – The Conversation AU
Article feature image
Novavax is absent from Australia’s 2021 vaccination schedule. But it could be a useful booster later on – The Conversation AU